206 related articles for article (PubMed ID: 22041313)
1. [If no-acid, no-heartburn? New physiopathological mechanisms of the gastroesophageal reflux disease].
Remes-Troche JM; Ramírez-Cervantes KL; Vela MF
Rev Gastroenterol Mex; 2011; 76(3):237-46. PubMed ID: 22041313
[TBL] [Abstract][Full Text] [Related]
2. Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease.
Vela MF
Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):665-72. PubMed ID: 19072344
[TBL] [Abstract][Full Text] [Related]
3. Precise role of acid in non-erosive reflux disease.
Wang C; Hunt RH
Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838
[TBL] [Abstract][Full Text] [Related]
4. 24-hour ambulatory pH-metry in patients with refractory heartburn: a prospective study.
Talaie R; Forootan M; Donboli K; Dadashzadeh N; Sadeghi A; Poorsaadat S; Moghimi B; Mohammad Alizadeh AH; Zali MR
J Gastrointestin Liver Dis; 2009 Mar; 18(1):11-5. PubMed ID: 19337627
[TBL] [Abstract][Full Text] [Related]
5. Survey of findings in patients having persistent heartburn on proton pump inhibitor therapy.
Mandaliya R; DiMarino AJ; Cohen S
Dis Esophagus; 2016 Jan; 29(1):27-33. PubMed ID: 25294046
[TBL] [Abstract][Full Text] [Related]
6. Untangling Nonerosive Reflux Disease From Functional Heartburn.
Patel D; Fass R; Vaezi M
Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1314-1326. PubMed ID: 32246998
[TBL] [Abstract][Full Text] [Related]
7. Functional heartburn and non-erosive reflux disease.
Savarino V; Savarino E; Parodi A; Dulbecco P
Dig Dis; 2007; 25(3):172-4. PubMed ID: 17827934
[TBL] [Abstract][Full Text] [Related]
8. Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease.
Malhotra A; Freston JW; Aziz K
J Clin Gastroenterol; 2008 Mar; 42(3):271-8. PubMed ID: 18223497
[TBL] [Abstract][Full Text] [Related]
9. Refractory heartburn: comparison of intercellular space diameter in documented GERD vs. functional heartburn.
Vela MF; Craft BM; Sharma N; Freeman J; Hazen-Martin D
Am J Gastroenterol; 2011 May; 106(5):844-50. PubMed ID: 21179012
[TBL] [Abstract][Full Text] [Related]
10. Symptom association latency during ambulatory reflux monitoring: a review of 1445 symptoms.
Abdul-Hussein M; Castell D
Dis Esophagus; 2017 Oct; 30(10):1-6. PubMed ID: 28859384
[TBL] [Abstract][Full Text] [Related]
11. Role of the gastric refluxate in gastroesophageal reflux disease: acid, weak acid and bile.
Richter JE
Am J Med Sci; 2009 Aug; 338(2):89-95. PubMed ID: 19590427
[TBL] [Abstract][Full Text] [Related]
12. [Underlying Mechanisms and Management of Refractory Gastroesophageal Reflux Disease].
Lee KJ
Korean J Gastroenterol; 2015 Aug; 66(2):70-4. PubMed ID: 26289239
[TBL] [Abstract][Full Text] [Related]
13. The nonerosive reflux disease-gastroesophageal reflux disease controversy.
Winter JW; Heading RC
Curr Opin Gastroenterol; 2008 Jul; 24(4):509-15. PubMed ID: 18622168
[TBL] [Abstract][Full Text] [Related]
14. Antireflux surgery in the proton pump inhibitor era.
Bulsiewicz WJ; Madanick RD
Cleve Clin J Med; 2012 Apr; 79(4):273-81. PubMed ID: 22473727
[TBL] [Abstract][Full Text] [Related]
15. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
16. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy.
Savarino E; Zentilin P; Tutuian R; Pohl D; Casa DD; Frazzoni M; Cestari R; Savarino V
Am J Gastroenterol; 2008 Nov; 103(11):2685-93. PubMed ID: 18775017
[TBL] [Abstract][Full Text] [Related]
17. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.
Savarino E; Marabotto E; Zentilin P; Frazzoni M; Sammito G; Bonfanti D; Sconfienza L; Assandri L; Gemignani L; Malesci A; Savarino V
Dig Liver Dis; 2011 Jul; 43(7):542-7. PubMed ID: 21376679
[TBL] [Abstract][Full Text] [Related]
18. Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients.
Ortiz V; Ponce M; Fernández A; Martínez B; Ponce JL; Garrigues V; Ponce J
Obesity (Silver Spring); 2006 Apr; 14(4):696-700. PubMed ID: 16741272
[TBL] [Abstract][Full Text] [Related]
19. Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.
Shimatani T; Sugimoto M; Nishino M; Adachi K; Furuta K; Ito M; Kurosawa S; Manabe N; Mannen K; Hongo M; Chiba T; Kinoshita Y;
J Gastroenterol Hepatol; 2012 May; 27(5):899-906. PubMed ID: 22098590
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
Tack J; Koek G; Demedts I; Sifrim D; Janssens J
Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
